These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32363793)

  • 1. Are we really studying persister cells?
    Song S; Wood TK
    Environ Microbiol Rep; 2021 Feb; 13(1):3-7. PubMed ID: 32363793
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies targeting persister cell formation in bacterial pathogens.
    Khan F; Pham DTN; Tabassum N; Oloketuyi SF; Kim YM
    Crit Rev Microbiol; 2020 Nov; 46(6):665-688. PubMed ID: 33022189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial persistence: Fundamentals and clinical importance.
    Jung SH; Ryu CM; Kim JS
    J Microbiol; 2019 Oct; 57(10):829-835. PubMed ID: 31463787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosome dependence of persister cell formation and resuscitation.
    Wood TK; Song S; Yamasaki R
    J Microbiol; 2019 Mar; 57(3):213-219. PubMed ID: 30806978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
    Defraine V; Fauvart M; Michiels J
    Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells.
    Roberts ME; Stewart PS
    Microbiology (Reading); 2005 Jan; 151(Pt 1):75-80. PubMed ID: 15632427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subinhibitory concentrations of antibiotics on the emergence of drug resistant bacteria in vitro.
    Grassi GG; Ferrara A; Navone A; Sala P
    J Antimicrob Chemother; 1980 Mar; 6(2):217-23. PubMed ID: 7380767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Automated microbial sensitivity tests noting the difference in bacterial growth profiles--determination of the minimal inhibitory concentration (MIC) of bacteria contaminated by drug-resistant mutant strains].
    Miike H; Ebina Y; Hashimoto H; Miyaji T
    Iyodenshi To Seitai Kogaku; 1983 Apr; 21(2):100-5. PubMed ID: 6655991
    [No Abstract]   [Full Text] [Related]  

  • 10. Combatting Bacterial Persister cell infections by auranofin?
    Asghari B; Sadeghi HR; Mazaherylaghab H
    Biomed Pharmacother; 2017 Dec; 96():1565-1566. PubMed ID: 28716566
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrazolium salts for MIC determination in microplates: why? Which salt to select? How?
    Grare M; Fontanay S; Cornil C; Finance C; Duval RE
    J Microbiol Methods; 2008 Sep; 75(1):156-9. PubMed ID: 18556078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric monitoring of bacterial susceptibility to antibiotics.
    Walberg M; Steen HB
    Methods Cell Biol; 2001; 64():553-66. PubMed ID: 11070855
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of bacteria to antimicrobial drugs and interpretation of results].
    Kulauzov M; Mihajlović-Ukropina M; Jelesić Z; Medić D; Kozoderović G
    Med Pregl; 2010; 63 Suppl 1():17-21. PubMed ID: 21438199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchrotron radiation infrared microspectroscopy to assess the activity of vancomycin against endocarditis vegetation bacteria.
    Batard E; Jamme F; Montassier E; Bertrand D; Caillon J; Potel G; Dumas P
    J Microbiol Methods; 2011 Jun; 85(3):235-8. PubMed ID: 21447359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial agents, bacterial resistance, and susceptibility tests.
    Dziarski R; Axler DA
    J Am Podiatr Med Assoc; 1985 Feb; 75(2):66-82. PubMed ID: 3884771
    [No Abstract]   [Full Text] [Related]  

  • 16. Eradicating Bacterial Persisters with Combinations of Strongly and Weakly Metabolism-Dependent Antibiotics.
    Zheng EJ; Stokes JM; Collins JJ
    Cell Chem Biol; 2020 Dec; 27(12):1544-1552.e3. PubMed ID: 32916087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Physiological Basis for Nonheritable Antibiotic Resistance.
    Pontes MH; Groisman EA
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-found fundamentals of bacterial persistence.
    Kint CI; Verstraeten N; Fauvart M; Michiels J
    Trends Microbiol; 2012 Dec; 20(12):577-85. PubMed ID: 22959615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the susceptibility of bacteria in biofilms to antibacterial agents.
    Anwar H; Dasgupta MK; Costerton JW
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2043-6. PubMed ID: 2073094
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioluminescent assay as a potential method of rapid susceptibility testing.
    Kouda M; Ouchi Y; Takasaki Y; Maeda T; Matsuzaki H; Nakaya R
    Microbiol Immunol; 1985; 29(4):309-15. PubMed ID: 4021849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.